Início › Linfoma de Burkitt › Maine

Ensaios clínicos de Linfoma de Burkitt em Maine

4 estudos para Linfoma de Burkitt estão buscando participantes em locais em Maine.

Cidades em Maine

West Scarborough4 estudos

Texto oficial do estudo (Inglês)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Maine Children's Cancer Program, Scarborough

RecrutandoFase 2

366 Days – 46 Years · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Maine Children's Cancer Program, Scarborough

RecrutandoFase 2

365 Days · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Eastern Maine Medical Center, Bangor
Maine Children's Cancer Program, Scarborough

RecrutandoFase 2

Idades de 1 a 30 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Eastern Maine Medical Center, Bangor
Maine Children's Cancer Program, Scarborough

RecrutandoFase 3

365 Days – 25 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT03959085

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.